The construct of psychopathy has received considerable attention from clinicians, researchers, and legal practitioners because of its demonstrated association with a range of outcomes of interest to the criminal justice system. The Psychopathy Checklist-Revised (PCL-R) is generally regarded as the premier assessment tool for measuring psychopathy in correctional and legal contexts, and the PCL-R is being used with increased frequency to address a variety of legal questions. This article provides a comprehensive examination and review of the PCL-R’s use in legal contexts. We begin by reviewing various uses (appropriate and inappropriate) of the PCL-R in legal contexts, using the risk-need-responsivity (RNR) model as the conceptual framework. After reviewing available data regarding the use of the PCL-R in legal contexts, we review and synthesize psychometric research with psycholegal relevance, with a focus on the PCL-R’s construct validity, predictive validity, and interrater reliability. We then discuss the scientific acceptability and clinical utility of the PCL-R’s structural, predictive, and measurement properties for credibility in court, followed by sample cross-examination questions. We conclude with a review of admissibility issues relating to the use of the PCL-R in various legal proceedings.
Graduation rates in drug courts average 50% to 70%, but it is unclear what proportion of graduates responded to the drug court services and what proportion might not have had serious drug problems on entry. This study cluster analyzes urine drug screen results during the first 14 weeks of treatment on 284 participants from three misdemeanor drug courts. A four-cluster solution ( R2 > .75) produced distinct subgroups characterized by (a) consistently drug-negative urine specimens (34% of the sample), (b) consistently drug-positive specimens (21%), (c) consistently missed urine specimens (26%), and (d) urine specimens that began as drug positive but became progressively drug negative over time (19%). These data suggest that approximately one third of the participants might not have had serious drug problems on entry. Approximately one fifth appeared to respond to drug court services, and nearly one half continued to exhibit problems after 14 weeks. Implications for adaptive programming in drug courts are discussed.